Servicio de Información Comunitario sobre Investigación y Desarrollo - CORDIS

FP5

ANTI TUMOR ANGIOGENESI Informe resumido

Project ID: QLK3-CT-2002-02059
Financiado con arreglo a: FP5-LIFE QUALITY
País: Austria

Adenoviral EGR-1 expression to inhibit angiogenesis and tumor growth

A n important finding during the course of this project was that adenoviral EGR-1 overexpression caused a reduced responsiveness of endothelial cells to growth factors, prevented sprouting and tubule formation in vitro and prolonged expression triggered apoptosis. Furthermore, EGR-1 expressing viruses completely inhibited cell invasion and vessel formation in the murine Matrigel model and resulted in a dramatic blockade of tumor growth in a murine fibrosarcoma model.

An analysis of this phenomenon showed that that EGR-1 can actually promote two different activities, one pro-proliferative and pro-angiogenic when expressed at low growth factor-induced level, and an anti-proliferative, anti-angiogenic and pro-apoptotic when overexpressed in a sustained way following infection with recombinant adenoviruses.

Obviously, overexpression of EGR-1 causes the preferential induction of potent feed-back inhibitory mechanisms resulting in inhibition of angiogenesis. This could be likely caused by differential modification of EGR-1 when expressed following growth factor stimulation or following adenoviral expression (acetylation versus phosphorylation).

Información relacionada

Reported by

MEDICAL UNIVERSITY OF VIENNA
Lazarettgasse 19
1090 WIEN
Austria
See on map
Síganos en: RSS Facebook Twitter YouTube Gestionado por la Oficina de Publicaciones de la UE Arriba